The Anti-Tumor Effects of M1 Macrophage-Loaded Poly (ethylene glycol) and Gelatin-Based Hydrogels on Hepatocellular Carcinoma

Abstract

Background and Aims: Recently we reported that direct injection of M1 macrophages significantly caused tumor regression in vivo. Despite the promising result, a major limitation in translating this approach is the induction of acute inflammatory response. To improve the strategy, a biocompatible scaffold for cell presentation and support is essential to control cell fate. Here, we aimed to elucidate the anti-tumor effects of a poly(ethylene glycol) diacrylate (PEGdA) and thiolated gelatin poly(ethylene glycol) (Gel-PEG-Cys) cross-linked hydrogels capsulated with M1 macrophages in both in vitro and in vivo disease models.Methods: Hydrogels were made at 0.5% (w/v) Iragcure 2959 photoinitiator, 10% (w/v) PEGdA, and 10% (w/v) Gel-PEG-Cys. Monocytic THP-1 cells were loaded into hydrogels and differentiated into M1 macrophages with lipopolysaccharide (LPS) and interferon gamma (IFN-γ). The M1 hydrogels were then cocultivated with HCC cell-lines Hep3B and MHCC97L to investigate the anti-tumor capacities and the associated molecular profiles in vitro. A nude mice ectopic liver cancer model with dorsal window chamber (DWC) and a subcutaneous tumor model were both performed to validate the in vivo application of M1 hydrogels.Results: M1 hydrogels significantly decreased the viability of HCC cells (MHCC97L: -46%; Hep3B: -56.9%; P<0.05) compared to the control in vitro. In response to HCC cells, the hydrogel embedded M1 macrophages up-regulated nitrite and tumor necrosis factor alpha (TNF-α) activating caspase-3 induced apoptosis in the tumor cells. Increased tumor necrosis was observed in DWC filled with M1 hydrogels. In addition, mice treated with M1 hydrogels exhibited a significant 2.4-fold decrease in signal intensity of subcutaneous HCC tumor compared to control (P=0.036).Conclusion: M1 hydrogels induced apoptosis in HCC cells and tumor regression in vivo. Continuous development of the scaffold-based cancer immunotherapy may provide an alternative and innovative strategy against HCC.

Mussel-inspired conductive nanofibrous membranes repair myocardial infarction by enhancing cardiac function and revascularization

“…A recent in vitro study reported that polypeptide-conjugated Ppy-coated metal electrode displays excellent cytocompatibility 43 , 44 . Gelatin, a natural polymer, can be self-crosslinked into a monomolecular or network structure in dilute solutions 45 - 47 . In this study, as shown in Scheme 1 , GelMA was used as a shape-inducer and a toxicity-neutralizer to form the GelMA-Ppy nanoparticles during the process of oxidative polymerization.…”

Progress on Modulating Tumor‐Associated Macrophages with Biomaterials

“…Engineered implantable scaffolds could be used to modulate local immune cells and improve cancer treatments. Guerra et al used hydrogels to deliver M1‐like macrophages directly to the tumor to utilize their antitumor activity and overcome acute inflammation associated with systemic injection of M1‐like macrophages . Poly(ethylene glycol) diacrylate (PEGdA) was crosslinked with thiolated gelatin poly(ethylene glycol) (Gel–PEG–Cys) and subsequently loaded with THP‐1 monocytes, polarized to M1‐like macrophages with LPS and IFN‐ γ.…”

Myeloid deletion of phosphoinositide-dependent kinase-1 enhances NK cell-mediated antitumor immunity by mediating macrophage polarization

“…2 Moreover, M1 macrophages produce cytokines, such as IL-1β, tumor necrosis factor (TNF)α), interferon (IFN)-γ, interleukin (IL)-12 and IL-23, thereby stimulating tumor immunity mediated by cytotoxic lymphocytes, nature killer (NK) cells and CD8 + T cells. [3][4][5][6] As CD11c and MHC II were reported to highly expressed in M1-like macrophages, these two molecules are widely used as the markers of M1 macrophages. [7][8][9] The tumor progresses, the tumor microenvironment changes from type 1-to type 2-immunity status.…”